Judah Folkman
#4,085
Most Influential Person Now
American biologist
Judah Folkman's AcademicInfluence.com Rankings
Judah Folkmanphilosophy Degrees
Philosophy
#659
World Rank
#1280
Historical Rank
#299
USA Rank
Logic
#57
World Rank
#168
Historical Rank
#27
USA Rank
Download Badge
Biology Philosophy
Judah Folkman's Degrees
- Doctorate Medicine Harvard University
Why Is Judah Folkman Influential?
(Suggest an Edit or Addition)According to Wikipedia, Moses Judah Folkman was an American biologist and pediatric surgeon best known for his research on tumor angiogenesis, the process by which a tumor attracts blood vessels to nourish itself and sustain its existence. He founded the field of angiogenesis research, which has led to the discovery of a number of therapies based on inhibiting or stimulating neovascularization.
Judah Folkman's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Tumor angiogenesis: therapeutic implications. (1971) (9936)
- Angiogenesis in cancer, vascular, rheumatoid and other disease (1995) (7832)
- Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis (1996) (7081)
- Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. (1991) (5705)
- What is the evidence that tumors are angiogenesis dependent? (1990) (4646)
- Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth (1997) (4550)
- Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma (1994) (3409)
- Role of angiogenesis in tumor growth and metastasis. (2002) (2720)
- Role of cell shape in growth control (1978) (2405)
- Thalidomide is an inhibitor of angiogenesis. (1994) (2282)
- Transplacental carcinogenesis by stilbestrol. (1971) (2281)
- Angiogenic factors. (1987) (2162)
- Induction of angiogenesis during the transition from hyperplasia to neoplasia (1989) (1959)
- Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression (1995) (1903)
- Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. (1992) (1862)
- Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance (1997) (1778)
- Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. (1993) (1752)
- Clinical Applications of Research on Angiogenesis (1995) (1606)
- Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. (2000) (1602)
- ISOLATION OF A TUMOR FACTOR RESPONSIBLE FOR ANGIOGENESIS (1971) (1592)
- Clinical translation of angiogenesis inhibitors (2002) (1581)
- Angiogenesis: an organizing principle for drug discovery? (2007) (1408)
- The role of angiogenesis in tumor growth. (1992) (1351)
- Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. (1977) (1318)
- Blood Vessel Formation: What Is Its Molecular Basis? (1996) (1275)
- Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth (1990) (1259)
- Angiostatin induces and sustains dormancy of human primary tumors in mice (1996) (1242)
- Anti‐Angiogenesis: New Concept for Therapy of Solid Tumors (1972) (1201)
- Polymers for the sustained release of proteins and other macromolecules (1976) (1015)
- Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. (1987) (1015)
- Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. (1999) (980)
- Interferon alfa‐2a therapy for life‐threatening hemangiomas of infancy (1992) (977)
- A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane. (1988) (941)
- TUMOR DORMANCY IN VIVO BY PREVENTION OF NEOVASCULARIZATION (1972) (899)
- Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. (1984) (890)
- Opinion: Angiogenesis: an organizing principle for drug discovery? (2007) (860)
- HUMAN VASCULAR ENDOTHELIAL CELLS IN CULTURE Growth and DNA Synthesis (1974) (824)
- Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. (2008) (813)
- Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. (1994) (810)
- How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture. (1986) (793)
- Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. (2002) (792)
- SELF-REGULATION OF GROWTH IN THREE DIMENSIONS (1973) (788)
- Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix (1989) (779)
- Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. (1994) (767)
- Inhibition of angiogenesis in vivo by interleukin 12. (1995) (764)
- Tumor growth and neovascularization: an experimental model using the rabbit cornea. (1974) (757)
- Long-term culture of capillary endothelial cells. (1979) (750)
- Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. (1999) (727)
- Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy. (1999) (702)
- Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis (2003) (679)
- Fundamental concepts of the angiogenic process. (2003) (677)
- Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action. (2006) (650)
- Cellular markers that distinguish the phases of hemangioma during infancy and childhood. (1994) (646)
- Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. (1995) (645)
- Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. (1996) (626)
- Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. (1983) (612)
- Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. (1989) (578)
- Protamine is an inhibitor of angiogenesis (1982) (564)
- Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. (1997) (556)
- Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma (1991) (534)
- Cancer without disease (2004) (522)
- Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy (1994) (514)
- A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. (1985) (501)
- Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. (1993) (492)
- Tumor angiogenesis: a quantitative method for histologic grading. (1972) (492)
- Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. (1994) (482)
- How does extracellular matrix control capillary morphogenesis? (1989) (479)
- Role of Angiogenesis in Human Tumor Dormancy: Animal Models of the Angiogenic Switch (2006) (475)
- Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. (1997) (466)
- Tumor angiogenesis. (1985) (460)
- Antiangiogenic activity of the cleaved conformation of the serpin antithrombin. (1999) (460)
- Angiogenesis and angiogenesis inhibition: an overview. (1997) (454)
- Proceedings: Tumor angiogenesis factor. (1974) (452)
- A model of angiogenesis in the mouse cornea. (1996) (450)
- A simple procedure for the long-term cultivation of chicken embryos. (1974) (442)
- Angiogenesis and apoptosis. (2003) (431)
- Relation of vascular proliferation to tumor growth. (1976) (431)
- Mast cell heparin stimulates migration of capillary endothelial cells in vitro (1980) (421)
- Endostatin's antiangiogenic signaling network. (2004) (419)
- Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells. (1993) (414)
- Spastic Diplegia as a Complication of Interferon Alfa‐2a Treatment of Hemangiomas of Infancy (1998) (413)
- A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype. (2006) (411)
- Betacellulin: a mitogen from pancreatic beta cell tumors. (1993) (410)
- Vasculogenesis, Angiogenesis, and Growth Factors: Ephrins Enter the Fray at the Border (1998) (397)
- PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis. (2002) (397)
- 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. (1994) (395)
- Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia (2008) (368)
- Involvement of platelets in tumour angiogenesis? (1998) (365)
- Antiangiogenic therapy of transgenic mice impairs de novo tumor growth. (1996) (362)
- Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD. (1998) (360)
- Inhibition of tumor angiogenesis mediated by cartilage (1975) (354)
- Fighting cancer by attacking its blood supply. (1996) (350)
- Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage. (2006) (348)
- Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470 (2004) (336)
- The Hemostatic System as a Regulator of Angiogenesis* (2000) (331)
- Endogenous angiogenesis inhibitors (2004) (331)
- Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization. (2001) (330)
- The vascularization of tumors. (1976) (327)
- Reversal of Parenteral Nutrition–Associated Liver Disease in Two Infants With Short Bowel Syndrome Using Parenteral Fish Oil: Implications for Future Management (2006) (325)
- Platelets actively sequester angiogenesis regulators. (2009) (321)
- THE USE OF SILICONE RUBBER AS A CARRIER FOR PROLONGED DRUG THERAPY. (1964) (318)
- Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent. (1991) (315)
- The generation of endostatin is mediated by elastase. (1999) (307)
- Tumor angiogenesis and tissue factor (1996) (302)
- Kringle Domains of Human Angiostatin (1996) (298)
- Differentiation of vascular endothelium in the chick chorioallantois: a structural and autoradiographic study. (1974) (297)
- Combined Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor (EGFR) Blockade Inhibits Tumor Growth in Xenograft Models of EGFR Inhibitor Resistance (2009) (297)
- Angiogenesis-dependent diseases. (2001) (296)
- Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer (2001) (295)
- Isolations of a cartilage factor that inhibits tumor neovascularization. (1976) (292)
- Control of angiogenesis with synthetic heparin substitutes. (1989) (289)
- Down syndrome suppression of tumor growth and the role of the calcineurin inhibitor DSCR1 (2009) (287)
- Dose-dependent response of FGF-2 for lymphangiogenesis. (2004) (285)
- Regulation of Angiostatin Production by Matrix Metalloproteinase-2 in a Model of Concomitant Resistance* (1999) (284)
- Duodenal ulcer. Discovery of a new mechanism and development of angiogenic therapy that accelerates healing. (1991) (283)
- Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model. (2001) (280)
- Cell Shape and Phenotypic Expression in Chondrocytes (1983) (273)
- Tumor angiogenesis: a possible control point in tumor growth. (1975) (272)
- ANGIOGENESIS: INITIATION AND CONTROL * (1982) (269)
- APPLICATION OF THE BIOLOGICAL PRINCIPLE OF INDUCED OSTEOGENESIS FOR CRANIOFACIAL DEFECTS (1981) (269)
- Angiostatic steroids. Method of discovery and mechanism of action. (1987) (268)
- Angiogenesis Research: Guidelines for Translation to Clinical Application (2001) (268)
- Mast cells and tumor angiogenesis (1976) (266)
- New perspectives in clinical oncology from angiogenesis research. (1996) (265)
- Radiation therapy to a primary tumor accelerates metastatic growth in mice. (2001) (258)
- Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases. (1998) (257)
- Radiation abscopal antitumor effect is mediated through p53. (2003) (254)
- PPARα agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition (2008) (253)
- Hypoxic Induction of Endothelial Cell Growth Factors in Retinal Cells: Identification and Characterization of Vascular Endothelial Growth Factor (VEGF) as the Mitogen (1995) (251)
- Inhibition of angiogenesis through modulation of collagen metabolism. (1988) (247)
- Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily. (2002) (247)
- Antiangiogenic Therapy of a Recurrent Giant Cell Tumor of the Mandible With Interferon Alfa-2a (1999) (246)
- Preservation of Vascular Integrity in Organs perfused in vitro with a Platelet-rich Medium (1969) (246)
- Control of angiogenesis by heparin and other sulfated polysaccharides. (1992) (245)
- Vascularization of normal and neoplastic tissues grafted to the chick chorioallantois. Role of host and preexisting graft blood vessels. (1975) (244)
- Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients. (1993) (243)
- Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane. (1994) (243)
- Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470). (1994) (242)
- Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype. (2009) (234)
- Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours (1994) (232)
- Angiogenesis Inhibitors Generated by Tumors (1995) (232)
- Inhibition of angiogenesis. (1992) (228)
- Angiostatin: a circulating endothelial cell inhibitor that suppresses angiogenesis and tumor growth. (1994) (228)
- Switch to the angiogenic phenotype during tumorigenesis. (1991) (227)
- Avascular and vascular phases of tumour growth in the chick embryo. (1977) (227)
- Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy. (2010) (226)
- In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor. (1996) (222)
- Transcriptional network governing the angiogenic switch in human pancreatic cancer (2007) (221)
- Tumoral vascularity as a prognostic factor in cancer. (1996) (219)
- Isolation and characterization of endothelial progenitor cells from mouse embryos. (1998) (218)
- Tumor Behavior in Isolated Perfused Organs: In Vitro Growth and Metastases of Biopsy Material in Rabbit Thyroid and Canine Intestinal Segment (1966) (214)
- Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity. (2000) (211)
- A possible mechanism for inhibition of angiogenesis by angiostatic steroids: induction of capillary basement membrane dissolution. (1986) (210)
- Growth and metastasis of tumor in organ culture (1963) (208)
- Blood-Based Biomarkers of SU11248 Activity and Clinical Outcome in Patients with Metastatic Imatinib-Resistant Gastrointestinal Stromal Tumor (2007) (206)
- Omega-3 Fatty Acid Supplementation Prevents Hepatic Steatosis in a Murine Model of Nonalcoholic Fatty Liver Disease (2005) (204)
- Cancer: looking outside the genome (2000) (201)
- Maternal preeclampsia predicts the development of bronchopulmonary dysplasia. (2010) (200)
- A Feasibility Trial of Antiangiogenic (Metronomic) Chemotherapy in Pediatric Patients With Recurrent or Progressive Cancer (2005) (199)
- Prolonged tumor dormancy by prevention of neovascularization in the vitreous. (1976) (194)
- Hepatic vascular anomalies in infancy: a twenty-seven-year experience. (1996) (189)
- VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients (2012) (189)
- Angiogenesis is stimulated by a tumor‐derived endothelial cell growth factor (1985) (185)
- Isolation, characterization, and localization of heparin-binding growth factors in the heart. (1990) (185)
- Fine structure of vascular endothelium in culture. (1975) (183)
- Blue Rubber Bleb Nevus Syndrome: Surgical Eradication of Gastrointestinal Bleeding (2005) (182)
- Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA. (1998) (181)
- Toward an Understanding of Angiogenesis: Search and Discovery (2015) (180)
- Evidence by molecular profiling for a placental origin of infantile hemangioma. (2005) (178)
- Angiogenesis Inhibitors: A New Class of Drugs (2003) (176)
- An orally delivered small-molecule formulation with antiangiogenic and anticancer activity (2008) (174)
- Angiogenesis and breast cancer. (1994) (171)
- Successful treatment of infantile hemangiomas with interferon-α-2b (1997) (171)
- Influence of geometry on control of cell growth. (1975) (171)
- Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis. (2010) (167)
- Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin. (2005) (167)
- Vascular endothelial growth factor expression and tumor angiogenesis are regulated by androgens in hormone responsive human prostate carcinoma: evidence for androgen dependent destabilization of vascular endothelial growth factor transcripts. (2001) (165)
- Differential Effects of Vascular Endothelial Growth Factor Receptor-2 Inhibitor ZD6474 on Circulating Endothelial Progenitors and Mature Circulating Endothelial Cells: Implications for Use as a Surrogate Marker of Antiangiogenic Activity (2005) (165)
- Accelerated healing of duodenal ulcers by oral administration of a mutein of basic fibroblast growth factor in rats. (1994) (160)
- Tumor angiogenesis activity in cells grown in tissue culture. (1976) (160)
- Successful treatment of an angiogenic disease. (1989) (160)
- Horizontal transfer of DNA by the uptake of apoptotic bodies. (1999) (159)
- Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch (2006) (158)
- The fate of intravenously administered bFGF and the effect of heparin. (1989) (158)
- Progressive growth of infantile cutaneous hemangiomas is directly correlated with hyperplasia and angiogenesis of adjacent epidermis and inversely correlated with expression of the endogenous angiogenesis inhibitor, IFN-beta. (1999) (156)
- Tumor angiogenesis: iris neovascularization at a distance from experimental intraocular tumors. (1973) (155)
- In vitro characteristics of endothelium from hemangiomas and vascular malformations. (1982) (153)
- Angiogenic Activity as a Marker of Neoplastic and Preneoplastic Lesions of the Human Bladder (1980) (152)
- The sequence of events in the regression of corneal capillaries. (1978) (152)
- Antiangiogenic gene therapy. (1998) (149)
- Control of tumor growth in animals by infusion of an angiogenesis inhibitor. (1980) (149)
- Use of Demineralized Allogeneic Bone Implants for the Correction of Maxillocraniofacial Deformities (1981) (149)
- gro-beta, a -C-X-C- chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice (1995) (148)
- Normal ranges of angiogenesis regulatory proteins in human platelets (2010) (146)
- Persistence of microscopic human cancers in mice: alterations in the angiogenic balance accompanies loss of tumor dormancy (2002) (144)
- The effect of fibrin on cultured vascular endothelial cells. (1979) (144)
- Minimizing long-term tumor burden: the logic for metronomic chemotherapeutic dosing and its antiangiogenic basis. (2003) (143)
- A peptide trivalent arsenical inhibits tumor angiogenesis by perturbing mitochondrial function in angiogenic endothelial cells. (2003) (142)
- 2-methoxyestradiol inhibits hypoxia-inducible factor-1{alpha} and suppresses growth of lesions in a mouse model of endometriosis. (2008) (140)
- Angiogenic activity of adipose tissue. (1988) (139)
- Endothelial cells and angiogenic growth factors in cancer growth and metastasis. Introduction. (1990) (139)
- Platelet-associated PF-4 as a biomarker of early tumor growth. (2008) (139)
- Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. (1995) (139)
- Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice. (2003) (137)
- HUMAN VASCULAR ENDOTHELIAL CELLS IN CULTURE (1974) (135)
- Cloning and expression of cDNA encoding human betacellulin, a new member of the EGF family. (1993) (133)
- Inhibition of neovascularization by an extract derived from vitreous. (1977) (133)
- 1 – Tension and Compression as Basic Determinants of Cell Form and Function: Utilization of a Cellular Tensegrity Mechanism (1989) (133)
- Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer (2012) (129)
- A family of angiogenic peptides (1987) (129)
- Inhibition of tumor growth, vascularization, and collagenolysis in the rabbit cornea by medroxyprogesterone. (1981) (127)
- Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults. (2007) (126)
- Therapeutic angiogenesis in ischemic limbs. (1998) (126)
- Endostatin inhibits the vascular endothelial growth factor-induced mobilization of endothelial progenitor cells. (2003) (123)
- Doxycycline treatment for lymphangioleiomyomatosis with urinary monitoring for MMPs. (2006) (123)
- Zinc-dependent dimers observed in crystals of human endostatin. (1998) (123)
- Therapeutic efficacy of endostatin exhibits a biphasic dose-response curve. (2005) (123)
- Is angiogenesis an organizing principle in biology and medicine? (2007) (122)
- Role of vascular factors, including angiogenesis, in the mechanisms of action of sucralfate. (1991) (117)
- Endothelial-Directed Hepatic Regeneration After Partial Hepatectomy (2003) (115)
- Treatment of plasma cell granuloma of the lung with radiation therapy. A report of two cases and a review of the literature (1986) (115)
- Zinc-binding of endostatin is essential for its antiangiogenic activity. (1998) (114)
- Tumor dormancy due to failure of angiogenesis: role of the microenvironment (2008) (114)
- Hypothesis: Induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients (2004) (114)
- Regression of experimental iris neovascularization with systemic alpha-interferon. (1993) (114)
- Oligomerization-Dependent Regulation of Motility and Morphogenesis by the Collagen Xviii Nc1/Endostatin Domain (2001) (113)
- Increased Expression of Urinary Matrix Metalloproteinases Parallels the Extent and Activity of Vascular Anomalies (2005) (110)
- A strategy to discover circulating angiogenesis inhibitors generated by human tumors. (1995) (110)
- Magnetic modulation of release of macromolecules from polymers. (1981) (109)
- Antitumor activity of endostatin against carcinogen-induced rat primary mammary tumors. (2000) (108)
- Dendritic cells support angiogenesis and promote lesion growth in a murine model of endometriosis (2008) (108)
- Human vascular endothelial cells in culture. Lack of response to serum growth factors. (1976) (106)
- One Month of Sustained Release of Insulin from a Polymer Implant (1980) (106)
- Conditioned medium from mouse sarcoma 180 cells contains vascular endothelial growth factor. (1990) (106)
- Heterogeneity of angiogenic activity in a human liposarcoma: a proposed mechanism for "no take" of human tumors in mice. (2001) (105)
- Prolonged dormancy of human liposarcoma is associated with impaired tumor angiogenesis (2006) (105)
- Endostatin inhibits the growth of endometriotic lesions but does not affect fertility. (2005) (105)
- The combination of antiagniogenic agents to inhibit primary tumor growth and metastasis (1993) (104)
- Recombinant human betacellulin. Molecular structure, biological activities, and receptor interaction. (1994) (103)
- Can mosaic tumor vessels facilitate molecular diagnosis of cancer? (2001) (101)
- Tumor‐vascular interactions and tumor dormancy (2008) (101)
- Suppression of tumor growth with recombinant murine angiostatin. (1997) (99)
- Angiogenesis in psoriasis: therapeutic implications. (1972) (99)
- A 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity. (2005) (97)
- Regulation of angiogenesis: a new function of heparin. (1985) (97)
- Editorial: Is Tissue Mass Regulated by Vascular Endothelial Cells? Prostate as the First Evidence. (1998) (96)
- Elevation of cerebrospinal fluid levels of basic fibroblast growth factor in moyamoya and central nervous system disorders. (1997) (94)
- What Does Radiotherapy Do to Endothelial Cells? (2001) (93)
- Addressing tumor blood vessels (1997) (93)
- Nonsteroidal antiinflammatory drugs differentially suppress endometriosis in a murine model. (2005) (91)
- Human betacellulin, a member of the EGF family dominantly expressed in pancreas and small intestine, is fully active in a monomeric form. (1996) (90)
- What is the role of endothelial cells in angiogenesis? (1984) (90)
- Analysis of experimental antiangiogenic therapy. (1993) (89)
- Prevention of Intra-abdominal Adhesions Using the Antiangiogenic COX-2 Inhibitor Celecoxib (2005) (89)
- Angiogenesis and its inhibitors. (1985) (89)
- Phase II Study of the Antiangiogenic Agent SU5416 in Patients with Advanced Soft Tissue Sarcomas (2004) (89)
- Isolation and characterization of human heparin. (1992) (89)
- Tumor vascularity, proliferation, and apoptosis in human melanoma micrometastases and macrometastases. (1998) (89)
- Hirschsprung's disease: associated abnormalities and demography. (1992) (87)
- Elevated basic fibroblast growth factor levels in patients with pulmonary arterial hypertension. (2004) (86)
- Protein kinase C activators suppress stimulation of capillary endothelial cell growth by angiogenic endothelial mitogens (1987) (86)
- Rosiglitazone and delayed onset of proliferative diabetic retinopathy. (2008) (86)
- Endostatin inhibits angiogenesis by stabilization of newly formed endothelial tubes (2004) (86)
- Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma in adults. (2008) (86)
- Effect of antiangiogenic therapy on slowly growing, poorly vascularized tumors in mice. (2001) (85)
- Generation of multiple angiogenesis inhibitors by human pancreatic cancer. (2001) (85)
- Elevated basic fibroblast growth factor in the serum of patients with Duchenne muscular dystrophy (1994) (84)
- TUMOR ANGIOGENESIS (1972) (84)
- PPARα Deficiency in Inflammatory Cells Suppresses Tumor Growth (2007) (82)
- Adipose tissue growth and regression are regulated by angiopoietin-1. (2003) (80)
- A novel noninvasive model of endometriosis for monitoring the efficacy of antiangiogenic therapy. (2006) (80)
- Looking for a good endothelial address. (2002) (77)
- Successful treatment of infantile hemangiomas with interferon-alpha-2b. (1997) (77)
- Silicone Rubber: A New Diffusion Property Useful for General Anesthesia (1966) (77)
- Doxycycline induces membrane expression of VE‐cadherin on endothelial cells and prevents vascular hyperpermeability (2008) (76)
- Clearance of endotoxin by platelets: role in increasing the accuracy of the Limulus gelation test and in combating experimental endotoxemia. (1973) (75)
- Successful antiangiogenic therapy of giant cell angioblastoma with interferon alfa 2b: report of 2 cases. (2002) (75)
- Circulating Endothelial Progenitor Cells Are Up-Regulated in a Mouse Model of Endometriosis (2011) (74)
- Ultrastructural autoradiographic studies of the early vasoproliferative response in tumor angiogenesis. (1973) (73)
- Tumor‐induced angiogenesis: Lack of inhibition by irradiation (1975) (73)
- Expression of acidic and basic fibroblast growth factors in human and bovine vascular smooth muscle cells. (1990) (71)
- Portacaval shunt for glycogen storage disease: value of prolonged intravenous hyperalimentation before surgery. (1972) (70)
- Is tissue mass regulated by vascular endothelial cells? Prostate as the first evidence. (1998) (69)
- Importance of size, sulfation, and anticoagulant activity in the potentiation of acidic fibroblast growth factor by heparin. (1989) (68)
- Vascular physiology. A family of angiogenic peptides. (1987) (68)
- Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma. (2007) (68)
- Incipient angiogenesis. (2000) (68)
- Disruption of the KEX1 gene in Pichia pastoris allows expression of full‐length murine and human endostatin (1999) (67)
- Is there a role for nitric oxide in tumor angiogenesis? (1998) (66)
- What is the role of thymidine phosphorylase in tumor angiogenesis. (1996) (66)
- What is the role of angiogenesis in metastasis from cutaneous melanoma? (1987) (65)
- Angiogenesis research: from laboratory to clinic. (1999) (65)
- Role of Vascular Endothelial Growth Factor–A in Recurrent Respiratory Papillomatosis (2005) (64)
- Angiogenesis by capillary endothelial cells in culture. (1980) (64)
- Lymphangiogenesis New Mechanisms (2002) (64)
- Isolation of the nonhistone proteins of rat Walker carcinoma 256. (1973) (64)
- Angiogenesis capacity as a diagnostic marker for human eye tumors. (1979) (64)
- Transplantation of fetal intestine: survival and function in a subcutaneous location in adult animals. (1974) (63)
- Treatment of murine hemangioendotheliomas with the angiogenesis inhibitor AGM-1470. (1995) (62)
- Basic fibroblast growth factor modulates the mitogenic potency of the platelet-derived growth factor (PDGF) isoforms by specific upregulation of the PDGF alpha receptor in vascular smooth muscle cells. (1992) (62)
- Stem cell therapies benefit Alport syndrome. (2009) (62)
- Short synthetic endostatin peptides inhibit endothelial migration in vitro and endometriosis in a mouse model. (2006) (60)
- 1-Deoxymannojirimycin inhibits capillary tube formation in vitro. Analysis of N-linked oligosaccharides in bovine capillary endothelial cells. (1992) (60)
- Matrigel cytometry: a novel method for quantifying angiogenesis in vivo. (2009) (58)
- Endostatin therapy reveals a U-shaped curve for antitumor activity (2006) (58)
- Consensus Micro RNAs Governing the Switch of Dormant Tumors to the Fast-Growing Angiogenic Phenotype (2012) (58)
- Angiogenic therapy of the human heart. (1998) (58)
- Angiogenesis--retrospect and outlook. (1992) (57)
- The route of lipid administration affects parenteral nutrition-induced hepatic steatosis in a mouse model. (2005) (57)
- Inhibition of p53 response in tumor stroma improves efficacy of anticancer treatment by increasing antiangiogenic effects of chemotherapy and radiotherapy in mice. (2006) (57)
- Transcriptional regulation of basic fibroblast growth factor gene expression in capillary endothelial cells (1991) (57)
- The placenta theory and the origin of infantile hemangioma. (2007) (55)
- Angiogenic zip code (1999) (55)
- Endothelial progenitor cells contribute to accelerated liver regeneration. (2007) (55)
- Inhibition of EGF signaling protects the diabetic retina from insulin-induced vascular leakage. (2013) (55)
- Interferon alpha therapy of haemangiomas in newborns and infants (1991) (54)
- Angiogenesis: initiation and modulation. (1983) (53)
- Sustained-release endotoxin. A model for inducing corneal neovascularization. (1991) (53)
- Linking Antibody Fc Domain to Endostatin Significantly Improves Endostatin Half-life and Efficacy (2008) (52)
- The role of heparin in angiogenesis. (1983) (52)
- Potent antitumor effects of ZD6474 on neuroblastoma via dual targeting of tumor cells and tumor endothelium (2008) (51)
- The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis. (1993) (51)
- Control of release kinetics of macromolecules from polymers (1980) (51)
- Basic fibroblast growth factor secreted by an animal tumor is detectable in urine. (1993) (50)
- Tumor angiogensis: role in regulation of tumor growth. (1974) (50)
- Endothelial regeneration: studies with human endothelial cells in culture. (1973) (49)
- Tumor angiogenesis in women with node-positive breast cancer. (1995) (49)
- Binding inhibition of angiogenic factors by heparan sulfate proteoglycans in aqueous humor: potential mechanism for maintenance of an avascular environment (2003) (49)
- Pharmacological Treatment of a Diffuse Arteriovenous Malformation of the Upper Extremity in a Child (2009) (49)
- Toward a new understanding of vascular proliferative disease in children. (1984) (49)
- Basic Fibroblast Growth Factor: A Missing Link between Collagen VII, Increased Collagenase, and Squamous Cell Carcinoma in Recessive Dystrophic Epidermolysis Bullosa (1998) (48)
- Demineralized bone implants for nonunion fractures, bone cysts, and fibrous lesions. (1999) (48)
- Adenovirus-mediated delivery of a soluble form of the VEGF receptor Flk1 delays the growth of murine and human pancreatic adenocarcinoma in mice. (2002) (48)
- Role of endogenous basic fibroblast growth factor in the healing of gastric ulcers in rats. (1997) (47)
- Angiogenesis and proteins of the hemostatic system (2003) (47)
- Intravesical bacille Calmette-Guérin induces the antiangiogenic chemokine interferon-inducible protein 10. (1999) (47)
- The influence of angiogenesis research on management of patients with breast cancer (2004) (46)
- Human intestine matures as nude mouse xenograft. (1991) (46)
- Endothelial growth factors and extracellular matrix regulate DNA synthesis through modulation of cell and nuclear expansion (1987) (46)
- Angiostatic steroids potentiated by sulfated cyclodextrins inhibit corneal neovascularization. (1991) (46)
- Inhibition of tumor angiogenesis by oral etoposide. (2010) (46)
- Oral heparin results in the appearance of heparin fragments in the plasma of rats. (1986) (45)
- Role of Endogenous Angiogenesis Inhibitors in Down Syndrome (2009) (44)
- Tumor Suppression by p53 Is Mediated in Part by the Antiangiogenic Activity of Endostatin and Tumstatin (2006) (44)
- Tumor angiogenesis. (1972) (43)
- Experimental retinal neovascularization induced by intravitreal tumors. (1977) (43)
- Binding of endostatin to endothelial heparan sulphate shows a differential requirement for specific sulphates. (2003) (43)
- Angiostatin regulates the expression of antiangiogenic and proapoptotic pathways via targeted inhibition of mitochondrial proteins. (2009) (42)
- Angiogenesis inhibitors and hypoxia (2003) (41)
- Endostatin lowers blood pressure via nitric oxide and prevents hypertension associated with VEGF inhibition (2012) (41)
- CDK2 translational down-regulation during endothelial senescence. (2005) (41)
- Prevention of carcinomatosis and bloody malignant ascites in the rat by an inhibitor of angiogenesis. (1984) (41)
- Interaction of serum and cell spreading affects the growth of neoplastic and non-neoplastic fibroblasts. (1981) (41)
- A new link in ovarian cancer angiogenesis: lysophosphatidic acid and vascular endothelial growth factor expression. (2001) (40)
- Treatment of Human Pancreatic Cancer in Mice with Angiogenic Inhibitors (2003) (39)
- Affinity of fibroblast growth factors for β-cyclodextrin tetradecasulfate (1990) (37)
- Controlled release of macromolecules: Biological studies☆ (1985) (36)
- Angiogenesis imaging. (2000) (36)
- ISOLATION OF A TUMOR FACTOR RESPONSIBLE (1970) (36)
- HSPG-Binding Peptide Corresponding to the Exon 6a-Encoded Domain of VEGF Inhibits Tumor Growth by Blocking Angiogenesis in Murine Model (2010) (36)
- Heparin-binding angiogenesis factors: detection by immunological methods. (1987) (35)
- Diagnostic and therapeutic applications of angiogenesis research. (1993) (35)
- Successful inhibition of intracranial human glioblastoma multiforme xenograft growth via systemic adenoviral delivery of soluble endostatin and soluble vascular endothelial growth factor receptor-2: laboratory investigation. (2008) (34)
- The New Angiotherapy (2002) (33)
- Experimental corneal neovascularisation using sucralfate and basic fibroblast growth factor. (1996) (33)
- Vascular injury in transplanted tissues. Fine structural changes in tumor, adult, and embryonic blood vessels. (1976) (32)
- History of Angiogenesis (2008) (32)
- How the field of controlled-release technology began, and its central role in the development of angiogenesis research. (1990) (31)
- Lymphoid depletion in ileal loops: mechanism and clinical implications. (1976) (31)
- DRUG PACEMAKERS IN THE TREATMENT OF HEART BLOCK* (1963) (31)
- Glycogen storage disease: new approaches to therapy. (1977) (31)
- Dendritic cells augment choroidal neovascularization. (2008) (30)
- 19 The Logic of Anti-angiogenic Gene Therapy (1999) (30)
- Is oncogene addiction angiogenesis-dependent? (2005) (29)
- Endothelial cell proliferation activity in benign prostatic hyperplasia and prostate cancer: an in vitro model for assessment. (1998) (29)
- Genes tell lymphatics to sprout or not (2004) (29)
- Betacellulin Induces Increased Retinal Vascular Permeability in Mice (2010) (28)
- Maintenance of G1 Checkpoint Controls in Telomerase-Immortalized Endothelial Cells (2004) (28)
- Angiogenesis in P‐ and E‐Selectin‐Deficient Mice (1998) (28)
- Urinary basic fibroblast growth factor. A biochemical marker for preosseous fibroproliferative lesions in patients with fibrodysplasia ossificans progressiva. (1998) (27)
- Report from the society for biological therapy and vascular biology faculty of the NCI workshop on angiogenesis monitoring. (2004) (26)
- Efficacy of antiangiogenic therapy with TNP-470 in superficial and invasive bladder cancer models in mice. (2000) (26)
- Intracerebral gas anesthesia by diffusion through silicone rubber. (1968) (25)
- DNA synthesis in endothelium of aortic segments in vitro. (1972) (25)
- An Endogenous Inhibitor of Angiogenesis derived from a Transitional Cell Carcinoma: Clipped β2-Glycoprotein-I (2006) (24)
- Bile duct enlargement by infusion of L-proline: potential significance in biliary atresia. (1979) (24)
- A Novel Anti-Vascular Therapy for Cancer (2004) (24)
- A New Family of Mediators of Tumor Angiogenesis (2001) (23)
- Additional corrections: interferon for hemangiomas of infancy. (1995) (23)
- Thalidomide therapy for Crohn's disease (2000) (23)
- Sensitivity of NSCLC cell lines bearing wild type and mutated EGFR to the VEGF/EGFR inhibitor ZD6474 (2005) (22)
- Cell Configuration, Substratum and Growth Control (1980) (22)
- Early Tumor Detection Using Platelet Uptake of Angiogenesis Regulators. (2004) (22)
- Systemic antiangiogenic therapy for choroidal neovascularization. What is the role of interferon alfa? (1992) (22)
- Doxycycline inhibits vascular leakage and prevents ovarian hyperstimulation syndrome in a murine model. (2007) (21)
- Angiogenesis and c-Jun. (2004) (21)
- Matrix metalloproteinases in the urine of patients with pulmonary arterial hypertension. (2005) (20)
- Adenocarcinoma of colon at ureterosigmoidostomy site 14 years after conversion to ileal loop. (1974) (20)
- Tumor Angiogenesis: Effect on Tumor Growth and Immunity (1975) (20)
- Surgical research: a contradiction in terms? (1984) (20)
- Production process for recombinant human angiostatin in Pichia pastoris (2000) (19)
- Is there a field of wound pharmacology? (1992) (19)
- Regional Control of Tumor Growth (2010) (19)
- En face stripping of vascular endothelium. (1972) (19)
- Tumor Angiogenesis Factor 1 (2006) (19)
- Tumor angiogenesis. (1974) (19)
- Long-term remission of Crohn's disease treated with thalidomide: A seminal case report (2004) (18)
- Reduction of smooth muscle hyperplasia in vein grafts in athymic rats. (1991) (18)
- Spontaneous Reversion of the Angiogenic Phenotype to a Nonangiogenic and Dormant State in Human Tumors (2014) (17)
- Potentiation of angiostatic steroids by a synthetic inhibitor of arylsulfatase. (1988) (17)
- Hypotheses on cell adhesion and actin cables. (1977) (17)
- Cerebral metabolism during profound hypothermia and circulatory arrest. (1961) (16)
- Tumor Angiogenesis: from Bench to Bedside (2008) (16)
- Urinary Matrix Metalloproteinases and their Endogenous Inhibitors Predict Hepatic Regeneration after Murine Partial Hepatectomy (2004) (16)
- A proposed cause for the hepatic dysfunction associated with parenteral nutrition. (1990) (15)
- New Approach to Analgesia and Anesthesia Anesthesia by Diffusion through Silicone Rubber (1968) (15)
- UICC study group on basic and clinical cancer research: Tumor angiogenesis: Meeting held at woods hole, MA, September 18–21,1993 (1994) (15)
- Correlation of 2-Methoxyestradiol Levels in Cord Blood and Complications of Prematurity (2010) (15)
- Mechanism of size limitation of bacterial colonies. (1972) (14)
- Blood Platelets Organize Pro- and Anti-Angiogenic Factors into Separate, Distinct Alpha Granules: Implications for the Regulation of Angiogenesis. (2006) (14)
- Regulation of endothelial growth factor action: solid state control by extracellular matrix. (1987) (14)
- Inhibition of neuroblastoma cell proliferation with omega-3 fatty acids and treatment of a murine model of human neuroblastoma using a diet enriched with omega-3 fatty acids in combination with sunitinib (2012) (14)
- Antiangiogenic Activity of a Matrix Protein (2003) (13)
- Phase II Study of the Antiangiogenic Agent SU 5416 in Patients with Advanced Soft Tissue Sarcomas (2004) (13)
- Better living through chemistry, constant monitoring, and prompt interventions: 26 years on home parenteral nutrition without major complications. (2008) (13)
- Endogenous inhibitors of angiogenesis. (1996) (12)
- The radiation abscopal anti-tumor effect is mediated through p53 (2002) (12)
- INHIBITION OF TUMOR ANGIOGENESIS BY A DIFFUSIBLE FACTOR FROM CARTILAGE (1975) (12)
- Angiogenesis: What Makes Blood Vessels Grow? (1986) (12)
- Endostatin finds a new partner: nucleolin (2007) (12)
- Endocrine Pacemaker for Complete Heart Block (1962) (12)
- Controlled drug release from polymers. (1978) (11)
- Dermatan Sulfate in Pharmaceutical Heparins (1987) (11)
- Vascular injury in transplanted tissues (1976) (11)
- Use of an animal model for the study of the role of human immunodeficiency virus 1 in the human intestine. (1992) (11)
- Splenosis is regulated by a circulating factor. (1994) (11)
- Urinary basic fibroblast growth factor: a noninvasive marker of progressive cystic renal disease in a child. (2000) (11)
- Time dependent suppression of wound healing with the angiogenesis inhibitor agm 1470 (1991) (11)
- INHIBITION OF VEGF PREVENTS OCULAR NEOVASCULARIZATION IN A MONKEY MODEL (1995) (11)
- Role of Vascular Endothelial Growth Factor a in Children with Acquired Airway Stenosis (2007) (11)
- Perfusion of the thyroid. (1972) (11)
- The effect of antilymphocyte serum on fetal rat intestine transplanted as free subcutaneous homografts. (1974) (10)
- The treatment of post-operative and peptic esophageal strictures after esophageal atresia repair (1987) (10)
- Influence of geometry on growth of normal and malignant cells. (1976) (9)
- Perforated gastric duplication with pulmonary communication: a case report. (1971) (9)
- Isolated perfusion of thymus. (1968) (9)
- Purification and characterization of two collagenase inhibitors from mouse sarcoma 180 conditioned medium (1994) (9)
- The effect of helium-oxygen mixtures on body temperature. (1974) (9)
- Discussion: Antiangiogenic therapy with interferon alpha for giant cell lesions of the jaws☆ (2002) (9)
- Tumour angiogenesis and tumour immunity (1978) (9)
- Inappropriate Angiogenic Response as a Novel Mechanism of Duodenal Ulceration and Impaired Healing (2011) (8)
- Angiogenesis in Vitro: Implications for Tumor Biology (1982) (8)
- The role of angiostatin in the spontaneous bone and prostate cancers of pet dogs. (2002) (8)
- Effect of administoed bFGF on acute and chronic duodenal ulcers, gastric secretion and acute mucosal lesions in rats (1990) (8)
- Chronic analgesia by silicone rubber diffusion. (1969) (8)
- Robert Edward Gross - July 2, 1905-October 11, 1988. (1995) (7)
- Antiangiogenic Therapy and p53 (2002) (7)
- Anastomosis of transplanted fetal rat intestine to the normal intestine of the host. (1973) (6)
- Focal brain suppression by means of a silicone rubber chemode. Technical note. (1969) (6)
- Strategies to Prolong the Nonangiogenic Dormant State of Human Cancer (2007) (6)
- Growth control in capillary endothelium. (1986) (6)
- Cultures of Segments of Human Fetal Intestine: Applications to Cytologic and Virologic Investigations 1 (1970) (6)
- Acrylamide Polymerization: New Method for Determining the Oxygen Content in Blood (1972) (6)
- Platelet PF-4 Is an Early Marker of Tumor Angiogenesis. (2006) (6)
- Inflammation and Angiogenesis (1989) (6)
- Interdisciplinary Challenges: Control of Angiogenesis (1989) (5)
- A New Method for purifying Heparin‐binding Growth Factors a (1989) (5)
- VEGF-A is elevated in CSF of pediatric patients undergoing surgery for hydrocephalus (2009) (5)
- Angiostatin and Endostatin: Angiogenesis Inhibitors in Blood and Stroma (2008) (5)
- Watson and DNA: Making a Scientific Revolution (2003) (5)
- Differential Effects ofVascular Endothelial Growth Factor Receptor-2 Inhibitor ZD 6474 on Circulating Endothelial Progenitors and Mature Circulating Endothelial Cells : Implications for Use as a SurrogateMarker of Antiangiogenic Activity (2005) (5)
- Regulation of the Angiogenesis Inhibitor Thrombospondin‐1 by the Breast Cancer Susceptibility Gene‐1 (BRCA1) (2011) (5)
- Beginning of angiogenesis research (2003) (5)
- Angiogenic Vascular Grafts1 (1987) (4)
- New method for rapid blood gas determination without blood sample. (1969) (4)
- Thalidomide for multiple myeloma. (2006) (4)
- Tumor Angiogenesis: Importance in Tumor Detection and Growth (1984) (4)
- The culture of Peyer's patches. (1968) (4)
- Diffusion of anesthetics and other drugs through silicone rubber: therapeutic implications. (1970) (4)
- SELF-REGULATION OF GROWTH I N T HREE D IMENSIONS* (1973) (4)
- [30] Perfusion of the thyroid gland☆ (1975) (4)
- Commentary Antiangiogenic gene therapy (1998) (4)
- Growth Control in Capillary Endothelium (1986) (4)
- BONE IMPLANTS AND INDUCED OSTEOGENESIS (1982) (4)
- gro-( 3 , a-CXC-Chemokine , Is an Angiogenesis Inhibitor That Suppresses the Growth ofLewis Lung Carcinoma in Mice By (2003) (3)
- Nutrition services improve health and save money: Evidence from Massachusetts (1993) (3)
- Affinity of fibroblast growth factors for beta-cyclodextrin tetradecasulfate. (1990) (3)
- Thalidomide is an inhibitor of angiogenesis ( fibroblast growth factor / rabbit cornea (2004) (3)
- Can irradiation of lewis lung carcinoma primary tumor cause the growth of lung metastases (1998) (3)
- Cancer without disease: Do inhibitors of blood-vessel growth found naturally in our bodies defend most of us against progression of cancer to a lethal stage? (2004) (3)
- Culture systems for studying malignancy (1979) (3)
- ELEVATED SERUM VASCULAR ENDOTHELIAL GROWTH FACTOR IN CHILDREN WITH CROHN'S DISEASE: 22 (1997) (3)
- Beta-35 is a transferrin-derived inhibitor of angiogenesis and tumor growth. (2011) (3)
- Transplacental carcinogenesis by stilbestrol. [Editorial] (1971) (3)
- Francis Daniels Moore: August 17, 1913-November 24, 2001. (2006) (3)
- Phase I trial results of recombinant human angiostatin (RHA) and radiotherapy (2001) (2)
- Angiogenic inhibitors: a fourth modality of anticancer therapy (2007) (2)
- Pyloromyotomy: Does surgery in infancy increase allergy? (1975) (2)
- A novel non-invasive mouse model of endometriosis for monitoring angiogenesis and the efficacy of anti-angiogenic therapy (2006) (2)
- CRITICAL ISSU-ES IN TUMOR MICROCIRCULATION, ANGIOGENESIS AND METASTASIS: BIOLOGICAL SIGNIFICANCE AND CLINICAL RELEVANCE (1993) (2)
- Silicone Rubber: Oxygen, Carbon Dioxide, and Nitrous Oxide Measurement in Gas Mixtures (1967) (2)
- Cost-effectiveness of medical nutrition therapy by registered dietitians for patients with hypercholesterolemia (1994) (2)
- DRUG PACEMAKERS IN THE TREATMENT OF HEART BLOCK (1963) (2)
- Protamine: A powerfulin vivo inhibitor of bone resorption (1984) (2)
- Cell Conformation and Growth Control (1982) (2)
- VEGF-Targeted Antiangiogenic Gene Therapy (2002) (2)
- Anesthesia by diffusion through silicone rubber. (1968) (2)
- Bovine aortic smooth muscle cells role of different growth factors for cellular replication (1989) (2)
- The Effect of bFGF and PDGF on Acute Gastric Mucosal Lesions, Chronic Gastritis and Chronic Duodenal Ulcer (1995) (1)
- Sucralfate. Role of endogenous sulfhydryls and basic fibroblast growth factor (bFGF). (1995) (1)
- Betacellulin Induces Increased Retinal Vascular Permeability in Proliferative Diabetic Retinopathy (2008) (1)
- Angiogenesis and Blood Supply (2005) (1)
- Rosiglitazone May Delay Progression to Proliferative Diabetic Retinopathy (2006) (1)
- A model to study development and immune function in the human small intestine. (1987) (1)
- New method for oxygen content in blood based on acrylamide polymerization. (1972) (1)
- Experimental closure of ventricular septal defects. (1956) (1)
- Cooperation among labs is appreciated (2001) (1)
- Lodamin (PEG-PLA-TNP-470), a novel formulation for oral administration of TNP-470 as a potent antiangiogenic and anti-cancer drug. (2008) (1)
- The Platelet Angiogenesis Proteome for Early Detection of Cancer (2006) (1)
- Patent dispute hangs over kringle 5 (2000) (1)
- Thalidomide for Crohn's disease. (2000) (1)
- Perfusion of the thyroid gland. (1975) (1)
- Matrix-Driven Translocation of Cells and Nonliving Particles (2005) (1)
- chapter 24 – Angiogenesis in Cardiovascular Disease (2004) (1)
- Don't practice on me. (1975) (1)
- From the lab to the clinic: one investigator's journey. (2002) (1)
- Microbead assay: a novel assay that detects endothelial cell proliferation and inhibition. (1998) (1)
- Improved pharmacokinetics and efficacy of endostatin by fusion with IgG Fc domain (2007) (1)
- Summary of Cancer Research Campaign Lecture Studies of the switch to the angiogenic state in animal and human tumours (1991) (1)
- Identification of novel Angiostatin binding partners using a protein array (27K) based high-throughput protein-protein-interaction screen (2008) (1)
- DIFFERENTIAL REGULATION OF VEGF/VPF AND BASIC FGF BY HYPOXIA (1994) (1)
- Activation of Human Platelets by Endotoxin (1975) (0)
- Terapias del futuro: Cáncer y suministro sanguíneo (1996) (0)
- Response: Re: A Model of Human Tumor Dormancy: An Angiogenic Escape From the Nonangiogenic Phenotype (2007) (0)
- Doxycycline Inhibits Vascular Leakage and Prevents the Development of Pulmonary Edema (2008) (0)
- Judah Folkman Therapeutic Angiogenesis in Ischemic Limbs (1998) (0)
- Erratum: (The Journal of Clinical Investigation (March 1998) 101:5 (1061)) (1998) (0)
- Letter: Limulus test. (1975) (0)
- Peptides pour traitement et prevention de l'endometriose (2004) (0)
- Tumor imaging using near-infrared labeled probes against proliferating endothelial cells (2001) (0)
- Bone Marrow – Derived Dendritic Cell Cultures and Transplantation (2008) (0)
- Can Angiogenesis Regulatory Proteins Guide Ultra-early Detection and Therapy of Recurrent Human Cancer? (2007) (0)
- DNA SYNTHESIS T H R O U G H MODULATION OF CELL AND NUCLEAR EXPANSION (0)
- Advances in Brief Antitumor Activity of Endostatin against Carcinogen-induced Rat Primary Mammary Tumors 1 (2000) (0)
- Anatomical Differences in Response to Angiogenesis (2008) (0)
- Angiogenesis inhibition and lung-cancer therapy (2014) (0)
- VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients (2012) (0)
- Methods for regulation of the size and growth of normal vascularized tissue (1998) (0)
- Focal B rain S uppression b y M eans o f a Silicone R ubber C hemode (1969) (0)
- , potential biomarker of angiogenesis Platelet-derived thrombospondin-1 is a critical negative regulator and (2010) (0)
- Oxygen consumption by acrylamide polymerization: A method for rapid screening of anticancer agents (1975) (0)
- Partial pressure of anesthetic gases and their mode of administration. (1967) (0)
- Antiangiogenic gene therapy delays growth of murine and human pancreatic adenocarcinoma in mice (2001) (0)
- Basic Fibroblast Growth Factor Secreted by an Animal T\imor Is Detectable in Urine1 (2006) (0)
- Prevention of the Angiogenic Switch in Human Breast (2006) (0)
- An experimental animal model of human tumor dormancy (2004) (0)
- , AND FOLKMAN (2003) (0)
- Optimal anti-angiogenic (metronomic) and anti-tumor doses of etoposide on angiogenesis, primary tumor growth and metastasis were established alone and in combination therapy. Etoposide inhibited endothelial and tumor cell proliferation, decreased vascular endothelial growth factor (VEGF) produc- tio (2010) (0)
- Radiation therapy plus ADFlk1-Fc has a synergistic effect against fibrosarcoma T241 in mice (2001) (0)
- Correlations between basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF), and clinical features of pulmonary arterial hypertension (PAH) (2002) (0)
- Can mosaic tumor vessels faa diagnosis of cancer (2016) (0)
- The Best-Laid Plans of Mice for Men and Women: New Directions for Angiogenesis Research (1999) (0)
- Anti-angiogenic and anti-tumor activities of PPARα ligands (2004) (0)
- A Rare Case of Mucormycosis in the Scalp Um Caso Raro de Mucormicose no Couro Cabeludo (2013) (0)
- Basic Fibroblast Growth Factor Secreted by an Animal T \ imor Is Detectable in Urine 1 (2006) (0)
- Storage of Heparin-Binding Endothelial Cell Growth Factors in the Cornea: a New Mechanism for Corneal Neovascularization (1987) (0)
- Abstracts of the Hans Selye Symposium on Neuroendocrinology and Stress (1989) (0)
- Selected Abstracts of the Institut Pasteur Euroconference on Angiogenesis, Paris, France 8–9 March 2001 (2004) (0)
- A Novel Secreted Form of the Angiogenesis Inhibitor Endostatin Prolongs Survival in Mice Inoculated with U-87 Tumor Xenografts (1998) (0)
- ProlongedTumorDormancyby Preventionof Neovascularization in the Vitreous1 (1976) (0)
- 16TH ANNUAL SAN ANTONIO B REAST C ANCER S YMPOSIUM (1993) (0)
- mannose-labeled glycopeptides from induced and uninduced (2001) (0)
- Continuous administration improves efficacy of endostatin therapy in mice. (2000) (0)
- released -granules and differentialy α proteins are organized into separate platelet Angiogenesis is regulated by a novel mechanism: Pro- and anti-angiogenic (2013) (0)
- P-476 P 63 and Thy-1 expression in endometriosis (2006) (0)
- Reply to “Limitations of combination anti-angiogenesis and chemotherapy” (2002) (0)
- Prevention des adherences chirurgicales a l'aide d'inhibiteurs selectifs du cox-2 (2004) (0)
- The regulation of body temperature with heliumoxygen mixtures (1974) (0)
- The development of endometriosis is dependent on the presence of dendritic cells in mice (2008) (0)
- Urinary matrix metallproteinases as a marker for angiostatin production in mice (2000) (0)
- Table 9.2, Endogenous Angiogenesis Promoters (2000) (0)
- and Activity of Vascular Anomalies Increased Expression of Urinary Matrix Metalloproteinases Parallels the Extent (2007) (0)
- Angiogenesis Research to Improve Therapies for Vascular Leak Syndromes, Intra-abdominal Adhesions, and Arterial Injuries (2007) (0)
- Comment on: A model of human tumor dormancy : An angiogenic escape from the nonangiogenic phenotype. Authors' reply (2007) (0)
- CAPILLARY ENDOTHELIAL CELL MIGRATION (2003) (0)
- Some Problems of Trial Design for Anti-Angiogenic Agents in Cancer Therapy (1994) (0)
- Heparin-testing methods. (1987) (0)
- Adipose tissue remodeling is coordinated with vascular maturation through shifts in angiopoletin-1 expression (2002) (0)
- Vitamin D Binding Protein-Macrophage Activating Factor ( DBP-maf ) Inhibits Angiogenesis and Tumor Growth in Mice 1 (2002) (0)
- Urological Survey: Abstracts: Principles of Oncology, and Tumors of Bladder, Penis and UrethraIntravesical Bacille Calmette-Guerin Induces the Antiangiogenic Chemokine Interferon-Inducible Protein 10 (1999) (0)
- SUSTAINED INHIBITION OF BRAIN TUMOR GROWTH BY RECOMBINANT ADENO-ASSOCIATED VIRUS ENCODING ENDOST ATIN (2017) (0)
- TumorAngiogenesisActivityin Cells Grown in Tissue Culture1 (1976) (0)
- Wilms’ Tumor: Surgical Aspects (1983) (0)
- The therapeutic role of angiogenesis in peptic ulcer disease (1992) (0)
- Proliferation inhibitor of endothellzellen and its use (1996) (0)
- Oxygen Content Determined by Acrylamide Polymerization: Screening of Anticancer Agents, Generation of Oxyhemoglobin Dissociation Curves, and Potential Applications (1979) (0)
- Antiangiogenic therapy of superficial and invasive bladder carcinoma models in mice (2001) (0)
- Running Head: Platelet-derived TSP-1 may be a biomarker (2017) (0)
- Molecular Cancer esearch iogenesis , Metastasis , and the Cellular Microenvironment R ional Control of Tumor Growth (2010) (0)
- Perfusion of the isolated rat limb. (1970) (0)
- Tumor Angiogenesis: General Principles and Therapeutic Approaches (2005) (0)
- Data shows medical nutrition therapy is cost-effective. (1994) (0)
- Clinical experience of UK medical (1998) (0)
- Member Type Year Elected to Membership Date of Death (2008) (0)
- Judah Folkman, MD (2008) (0)
- The Podium (2002) (0)
- Caring is what counts: patients yearn for "my doctor.". (1981) (0)
- Your health in the 21st century. The next revolution. (2005) (0)
- Methodes et compositions destinees a inhiber l'angiogenese (1999) (0)
- A tribute to Dr. Judah Folkman. (2008) (0)
- Tribute to professor Judah Folkman (2005) (0)
- Welcome message (2004) (0)
- Plenary Lectures, Named Lectures, Special Lectures (2016) (0)
- Convirtiendo la realimentación en cambios (1991) (0)
- Convertirse en un líder indispensable (2012) (0)
This paper list is powered by the following services:
Other Resources About Judah Folkman
What Schools Are Affiliated With Judah Folkman?
Judah Folkman is affiliated with the following schools:
